Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
Clinical trial NCT05615220 · COMPLETED
Trial details
- NCT number
- NCT05615220
- Sponsor
- Emalex Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-31
- Primary completion
- 2025-01-13
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.